Biofrontera Inc.: A Dermatology Company Scaling with Momentum

April 8, 2026

BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications

NETANYA, Israel and REHOVOT, Israel, April 10, 2026 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (the “Company”) today announced that it has completed the acquisition of 100% of Zorronet from Water.io (TASE: WATR). This acquisition marks BiomX’s entry into the defense, security and rescue sector and establishes a foundation for building a diversified portfolio of defense, rescue, and […]

April 10, 2026

Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer’s Disease 6-Month NDA Submission

Financing secures path to first NDA submission for buntanetap 6-Month symptomatic data readout anticipated Q1 2027 Alzheimer’s disease Phase 3 trial 75% enrolled Parkinson’s disease open-label study 28% enrolled MALVERN, Pa., April 10, 2026 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational […]

April 10, 2026

Why Lenders Are Lining Up Behind Near-Production Gold

VANCOUVER, British Columbia, April 10, 2026 (GLOBE NEWSWIRE) — Equity-Insider.com News Commentary — Central banks purchased roughly 850 tonnes of gold in 2025 and are on pace to match that volume in 2026, with previously inactive buyers across Asia broadening the demand base for the first time in years[1]. That structural accumulation has coincided with […]

April 10, 2026